CJC-1295 + Ipamorelin
$80.00
Product Description
CJC-1295 + Ipamorelin Blend combines a growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue (GHS) for synergistic GH axis stimulation. CJC-1295 (without DAC) extends GHRH signaling while Ipamorelin selectively activates the ghrelin receptor (GHS-R1a) without affecting cortisol or prolactin.
Blend Composition:
- CJC-1295 (No DAC): GHRH analog (Modified GRF 1-29)
- Ipamorelin: Selective GHS-R1a agonist pentapeptide
Research Applications:
- Synergistic GH pulse amplitude and frequency studies
- IGF-1 axis modulation without cortisol elevation
- Body composition and lean mass research
- Sleep architecture and GH secretion pattern analysis
- Age-related GH decline countermeasure studies